Bromelain is a group of protein-digesting enzymes from the pineapple plant, sold as a supplement for swelling, sore joints, sinus congestion, and digestion. Among the so-called systemic enzymes it has the most research behind it, including a human study showing that some of it reaches the bloodstream. That makes it a useful test case for what a supplement with a real, if modest, evidence base looks like up close.
This review goes use by use, from wisdom tooth surgery to knee arthritis, sinusitis, and muscle soreness. It then covers how much bromelain reaches your blood, what the GDU number on the label means, what one round of competitor-funded testing found about label potency, and the safety questions that matter most, especially for anyone taking a blood thinner or heading into surgery.
The short version
- The best-supported use is modest. Small trials after wisdom tooth surgery, pooled in four 2019 meta-analyses, found less pain at some point after surgery. The reviews disagree about when, and about swelling.
- Knee arthritis: not supported for bromelain alone. The one placebo-controlled trial found no benefit. Blends with trypsin and rutoside did better, mostly in trials without a placebo group and largely linked to their makers.
- Muscle soreness and sprains: null. The largest trial, 721 people with ankle sprains, found a bromelain, trypsin and rutoside blend no better than placebo.
- Sinusitis: weak evidence. In old trials in acute sinusitis, adding bromelain to standard treatment improved some symptoms. Germany licenses a low-dose bromelain tablet as an add-on for swelling after operations and injuries, especially of the nose and sinuses.
- Some reaches the blood, in trace amounts: micrograms in plasma after grams by mouth. There is no human evidence that it boosts quercetin absorption.
- Label potency varies. In testing paid for by a competing brand, 16 of 20 products, mostly lesser-known brands bought online, failed the potency check, including 3 whose labels stated no activity at all.
- Do not take it if you are allergic to pineapple, and talk to a clinician first if you take a blood thinner, have surgery coming up, or are pregnant or breastfeeding.
What bromelain actually is
Bromelain is not a single enzyme but a mixture of cysteine proteases, enzymes that cut proteins, along with smaller amounts of other plant compounds. Most supplements are made from the pineapple stem, and the main enzyme there, stem bromelain, is a different protein from the main enzyme in the fruit. A 2005 analysis found that commercial preparations consist mostly of stem bromelain.
It is sold in two very different ways. As a digestive enzyme, it is taken with meals to help break down protein in the gut. As a so-called systemic enzyme, it is taken between meals in the hope that some of it is absorbed and acts elsewhere in the body, the same idea behind serrapeptase and nattokinase. Most of the research, and most of this review, concerns the second use.
Its regulatory status varies. In the United States, the FDA lists bromelain as generally recognized as safe as a food enzyme, used in food processing such as tenderizing meat, and oral bromelain is sold as a dietary supplement. In Germany, a low-dose, enteric-coated bromelain tablet is a licensed pharmacy medicine for swelling after operations and injuries, especially of the nose and sinuses. And a bromelain-based gel called NexoBrid, approved by the FDA in December 2022, is applied directly to severe burns, where in trials it sharply reduced the need to cut away burned tissue surgically. That gel works on the wound surface at high concentration and tells you nothing about what a capsule does.
What the evidence actually shows
Nearly every bromelain trial studied people with a medical condition or recovering from surgery, and most were small. Here is where each common use stands.
| Use | What was tested | Best evidence | Our read |
|---|---|---|---|
| Pain and swelling after wisdom tooth surgery | Bromelain alone, about 100 to 1,000 mg a day for up to two weeks around surgery | Four 2019 meta-analyses of small trials: all found less pain at some point; they split on swelling | The best-supported use, and the effect is small |
| Swelling and bruising after facial surgery | Bromelain alone against placebo | Nose surgery (46 patients): less bruising, same swelling. Eyelid surgery (46 patients, same group): less swelling | Early and mixed |
| Knee osteoarthritis | Bromelain alone, 500 to 800 mg a day (200 to 400 mg in an open study of mild knee pain) | The one placebo-controlled trial (47 patients, 800 mg a day for 12 weeks) found no benefit | Not supported for bromelain alone |
| Osteoarthritis, enzyme blends | Bromelain with trypsin and rutoside | About as good as diclofenac in trials mostly without placebo; the two placebo-controlled trials were modestly positive and linked to the makers | Evidence for the blend, not for bromelain |
| Muscle soreness and sprains | Bromelain alone, 900 to 1,000 mg a day, and blends | Null for soreness in 39 people; null for muscle damage markers in cyclists; a 721-person sprain trial of a blend was null | Not supported |
| Sinusitis | Bromelain added to standard care | A 2006 review of three decades-old trials called it encouraging for acute sinusitis; newer studies are non-randomized or uncontrolled | Weak, mostly old evidence |
| Digestion | Bromelain combined with a prescription pancreatic enzyme | One 1970 crossover trial in 12 people with pancreatic insufficiency | No trials in healthy people |
| Heart, cancer, immunity, weight | One 12-week trial of bromelain alone on heart risk factors; otherwise mostly laboratory and animal studies | The heart risk factor trial (68 adults with diabetes) was null; a 2023 meta-analysis found no cardiovascular benefit | Unsupported |
Evidence summaries describe research, mostly in people with diagnosed conditions or recovering from surgery, and are not claims about what any supplement does for a healthy person.
Does it reach your bloodstream?
For bromelain to calm swelling anywhere outside the gut, it has to cross the intestinal wall intact. Unlike most systemic enzymes, it has a human study showing that some of it does. In 1997, researchers studied 19 healthy men and found intact bromelain in their blood; with repeated doses of 3 grams a day, about three times the top of the 100 to 1,000 milligram daily range used in trials of bromelain alone, levels in plasma reached as much as 5 nanograms per milliliter by 48 hours. The bromelain kept part of its activity and traveled bound to the blood's own protease-trapping proteins. The authors estimated that about 10.8 micrograms was present in plasma over the sampling period: micrograms in the blood after grams by mouth.
We found no published study that reports blood concentrations at ordinary supplement doses. The closest is an Italian and Romanian study of 40 surgical patients taking 500 milligrams twice a day for 30 days, published twice, which graded bromelain in serum on a 0 to 4 scale rather than measuring a concentration, and took no measurement before dosing. The German drug label describes blood levels as dose-dependent and in the picomolar range, which is very low.
You will often read that up to 40 percent of bromelain is absorbed intact. That figure comes from rats, not people. A widely cited 2012 review traces it to a 1979 German study that placed radiolabeled bromelain directly into the rats' small intestine, bypassing the stomach, and reported that up to 40 percent was absorbed in high-molecular form. Another review cites a 1988 rat study that gave bromelain by mouth, but there the 40 percent describes something else: the share of the radioactive tag in the rats' plasma that was still attached to protein. At that study's one-hour peak, each milliliter of plasma held about 0.003 percent of the dose as intact-sized bromelain. Neither study measured what a person absorbs from a capsule.
Bromelain is also sold as an absorption booster, most often paired with quercetin. We found no human study that measured whether bromelain changes quercetin absorption. The most-cited source we could find is a 1999 trial in men with chronic prostatitis, whose abstract states it without data. That trial's placebo-controlled comparison tested quercetin alone; the product containing bromelain and papain was given only in an unblinded follow-up group, with no absorption measurements. Our quercetin guide covers the forms that do have absorption data.
Swelling and pain after surgery
This is bromelain's strongest ground, and most of the evidence comes from wisdom tooth removal, a standard research model because the surgery is predictable and recovery is easy to measure.
Four meta-analyses published in 2019 pooled largely the same handful of small randomized trials. All four found less pain with bromelain at some point after surgery, but not at the same point: one found it only at day 7, another in the first 24 hours and at day 7, and a third at 48 to 72 hours. They split two and two on swelling, and three of the four found no effect on how far patients could open their mouths. A broader 2023 meta-analysis that pooled 9 trials across different conditions found a pain reduction that was statistically significant but small.
The individual trials, one of them published after the reviews, show why results vary:
- 2014, 34 patients. 150 milligrams a day, then 100 milligrams. No significant difference from placebo on swelling, pain, or mouth opening.
- 2014, 45 patients. 250 milligrams four times a day, starting the day before surgery. Less pain than placebo at every time point and better quality of life, comparable to the painkiller diclofenac. The reduction in swelling was not significant.
- 2016, 68 patients analyzed. A dose-finding crossover trial. Doses of 3,000 and 4,500 FIP units a day were no better than 1,000, and pooled bromelain versus placebo showed only a trend. Side effects were no more common than with placebo.
- 2024, 42 patients in three groups. Purified bromelain and a pineapple extract both reduced pain and swelling and the need for ibuprofen. Mouth opening did not differ.
Outside dentistry the evidence is thinner. After nose reshaping surgery, a 2025 placebo-controlled trial in 46 patients found less bruising and less bleeding into the white of the eye at day 7, but no difference in swelling. A 2026 trial in 46 patients after upper eyelid surgery, from the same research group, found less swelling on days 3, 7, and 11 at 600 milligrams a day for two weeks, and less bruising on day 3 only. A 2016 trial in 82 women after episiotomy reported better pain and wound healing scores.
Germany also licenses a low-dose bromelain medicine. It is approved as an add-on treatment for acute swelling after operations and injuries, especially of the nose and sinuses, at 56 to 190 milligrams a day for no more than four to five days without medical advice, less by weight than most US supplements provide, although weight says little about activity. The same label advises stopping bromelain before surgery because it may affect clotting, while the trials gave it around surgery under supervision. Whether to use it around a procedure is a decision for your surgeon.
Joints, muscles and injuries
Bromelain alone for knee arthritis. The one placebo-controlled trial randomized 47 people with moderate to severe knee osteoarthritis to 800 milligrams a day or placebo for 12 weeks. Only 31 finished, and there was no significant difference on the main score or any subscale; both groups improved on the disability measure, a reminder of how large placebo responses are in joint pain. A 2016 pilot in 40 patients compared 500 milligrams a day with diclofenac. Both groups improved at four weeks with no difference between them, a result the authors called inconclusive, and without a placebo group that design cannot separate either treatment from natural recovery. An earlier open study found that 77 adults with mild, recent knee pain improved more on 400 milligrams than on 200 milligrams a day, but it also had no placebo group.
Enzyme blends. Most of the positive arthritis data come from blends of bromelain with trypsin and rutoside, sold as Wobenzym and Phlogenzym. In trials of 90 people with hip arthritis and 103 with knee arthritis, the blend did about as well as diclofenac over six weeks, without placebo groups. The largest trial with a placebo arm, 150 people over 12 weeks, found that the blend and diclofenac both beat placebo on the main arthritis score, but only diclofenac beat placebo on a second standard score, and two of its authors worked for companies involved in making and selling the blend. A 2025 placebo-controlled crossover trial in 45 people with knee arthritis, designed mainly to study markers of inflammation and cartilage turnover, found better pain and symptom subscores on the blend than on placebo but no significant difference in the overall score, in an exploratory analysis not corrected for multiple comparisons; Nestlé Health Science fully sponsored it and supplied the blend, and three of its authors were company employees. A pooled analysis of manufacturer-sponsored trials found fewer side effects than with diclofenac, which is the blend's clearest advantage. None of this isolates what bromelain contributes. Our joint supplements guide covers options with stronger evidence.
Muscle soreness. In a 2002 trial of 39 people, 300 milligrams of bromelain three times a day did nothing for soreness, strength, or range of motion after a hard arm workout, and neither did ibuprofen. In 15 competitive cyclists over a six-day stage race, 1,000 milligrams a day did not change blood markers of muscle damage, although the bromelain group reported less fatigue on one day. Two small trials of multi-enzyme blends found better recovery of muscle function, but neither can isolate bromelain, and in one it was a minor ingredient. Our muscle recovery guide covers what has better support.
Sprains and injuries. The largest trial of all, 721 people with ankle sprains at 27 hospitals, tested the bromelain, trypsin, and rutoside blend against placebo and against each ingredient on its own, including bromelain. The blend did no better than placebo or the single ingredients, and the placebo group recovered at least as well. A study of a similar blend in marathon runners also found no reduction in inflammation.
Sinuses and allergies
Sinusitis is one of bromelain's longest-studied uses. A 2006 systematic review found three randomized trials of bromelain, all decades old, each reporting some benefit, and pooling the two in acute sinusitis suggested that bromelain added to standard treatment improved some symptoms. The reviewers called the evidence encouraging but limited, with a median quality score of 3 out of 5 across the herbal trials they reviewed. A broader 2023 systematic review of bromelain likewise concluded that it may be effective against sinusitis.
Newer studies are weaker by design. A German study of 116 children with acute sinusitis reported the shortest illness with bromelain alone (6.66 days) compared with standard care (7.95 days), but the treatments were not randomly assigned, and children given bromelain plus standard care did worst of all (9.06 days), a sign the groups differed from the start. A 12-patient pilot in chronic sinusitis after surgery had no control group. A 2020 review of alternative treatments for sinusitis and rhinitis, graded by an expert panel, placed bromelain among four therapies, with acupuncture, capsaicin, and butterbur, whose evidence it rated low to moderate-high, but noted that these had mostly been compared with placebo rather than with standard therapies. The German licensed tablet is approved as an add-on for swelling after operations and injuries, especially of the nose and sinuses, not for sinus infections themselves, and its label says not to use it in children under 12.
Seasonal allergies are a different story. We did not find a controlled trial of bromelain on its own for hay fever, which is why our allergy supplements guide rates it as better supported for sinusitis than for hay fever.
Digestion, heart health and other claims
Digestion. Because bromelain digests protein, helping with protein digestion is plausible, and it appears in many digestive enzyme blends. The human evidence is one 1970 crossover trial in 12 adults with chronic pancreatic insufficiency, a medical condition in which the pancreas does not make enough enzymes. A prescription pancreatic enzyme product with a bromelain shell improved fat absorption more than a standard product, and because the product's core alone matched the standard product for fat absorption but did less for protein digestion, the authors credited the added bromelain for the difference. We found no trial of bromelain for everyday indigestion in healthy people.
Heart and circulation. Bromelain reduces platelet clumping in test tubes, at concentrations far above those measured in human blood, and it reduced clot formation in rats at an oral dose that, scaled by body surface area, equals roughly 600 to 700 milligrams for an adult. The one placebo-controlled trial of bromelain alone on heart risk factors that we found randomized 68 adults with diabetes and at least one such risk factor to 1,050 milligrams a day or placebo for 12 weeks. It found no significant difference in fibrinogen, a clotting protein, or in blood lipids, blood pressure, blood sugar, C-reactive protein, or body measurements, although the two groups' fibrinogen levels differed at the start. A 2023 meta-analysis concluded that bromelain was not effective for cardiovascular disease. A small 2021 trial of an anthocyanin and bromelain combination in 18 young adults improved blood vessel function, but its design cannot separate bromelain's part. Bromelain also appears alongside nattokinase in popular circulation protocols; our nattokinase review covers that evidence.
Cancer and immunity. Laboratory studies are plentiful and human evidence is not. A small 1999 German study measured immune cell activity in 16 women with breast cancer and had no clinical outcomes. A 2021 systematic review of enzyme therapy in cancer care, mostly with multi-enzyme products, found no clear benefit. Anyone being treated for cancer should discuss any supplement with their oncology team.
Weight loss. We found no human trial of bromelain for weight loss.
Dosage: mg, GDU and what trials used
Bromelain labels usually give two numbers: a weight in milligrams and an activity, most often in GDU, or gelatin digesting units. The activity is what matters, because a milligram of weak bromelain and a milligram of strong bromelain are different doses. A common grade is 2,400 GDU per gram, so a 500 milligram capsule of that grade supplies about 1,200 GDU. To work out GDU per serving, multiply the milligrams by the GDU-per-gram figure and divide by 1,000.
What trials used. Trials of bromelain on its own used roughly 100 to 1,000 milligrams a day, usually split into two to four doses, for a few days to two weeks around surgery or up to 16 weeks for knee pain. Many trial reports give doses in milligrams without an activity figure, which makes them hard to match to today's labels, and in the one placebo-controlled dose-finding trial, higher was not better. The German licensed medicine uses a lower dose by weight than most of those trials: one tablet of 56 to 95 milligrams, labeled as 500 FIP units, once or twice a day. This is a description of the research, not a dosing recommendation.
Timing. Some trials for swelling, and the German label, give bromelain apart from food, with the label specifying about half an hour before a meal; digestive products are taken with meals. No human study has compared the two. In mice, bromelain given in an antacid kept more of its activity through the gut.
GDU measures how fast a sample digests gelatin. FIP units, common in Europe, measure how fast it digests casein, a milk protein, and MCU, or milk clotting units, measure something else again. Because each test uses a different substrate or measures a different reaction, there is no fixed conversion. A 2024 study that measured bromelain extracted from different parts of the pineapple plant found that the ratio between gelatin and casein units shifted from one part to another. The often-quoted rule that 1 GDU equals about 1.5 MCU is an industry convention, not a validated conversion. Even the licensed German tablet defines 500 FIP units as anywhere from 56 to 95 milligrams of bromelain.
How to choose a product
Label potency is a real problem. In 2023, NOW Foods, which sells its own bromelain, paid an independent enzyme laboratory to test 19 bromelain supplements bought on Amazon, plus its own, using the US Pharmacopeia method for GDU. Sixteen of the 20 failed NOW's potency check: 13 fell short of the activity on their label, and 3 listed only a weight with no activity claim but tested far below the usual 2,400 GDU per gram. By NOW's count, 12 contained less than a tenth of the activity claimed or expected. Four met or exceeded their labels, NOW's own among them. The caveats matter: a competitor commissioned and published the testing, each brand was tested once, the results were not peer-reviewed, and NOW deliberately skipped established natural and practitioner brands, so the results describe lesser-known online brands rather than the whole market.
- Buy by activity. Choose a product that states GDU or FIP units per serving, not just milligrams.
- Look for third-party testing, such as an NSF or USP seal, or a brand that publishes potency results for each batch.
- Know whether it is bromelain alone or a blend. The arthritis trials that looked best used bromelain with trypsin and rutoside, and a blend's results say nothing about bromelain on its own.
- Coating is not a guarantee. The German licensed tablet is enteric-coated; our enteric coating explainer covers what that kind of coating does and does not do.
- Pineapple is not a substitute. The fruit's main enzyme differs from the stem bromelain in most supplements, the amount is not standardized, and heat inactivates it, which is why canned pineapple can set in gelatin while fresh pineapple cannot.
Side effects and interactions
In short trials, bromelain is generally well tolerated. The most commonly reported side effects are digestive, such as gas, nausea, stomach upset, and diarrhea, along with headache. The German drug label lists allergic reactions, such as rash or asthma-like symptoms, as common, affecting between 1 in 100 and 1 in 10 users; stomach complaints or diarrhea as uncommon; and prolonged bleeding time as very rare.
Allergy. Bromelain is a known allergen. Workers who inhale the powder can develop occupational asthma, and in one early case eating pineapple set off the same reaction. People allergic to pineapple should not take it, and people with latex allergy or an allergy to papain may cross-react. Sensitization is not the same as allergy, though: antibodies to a sugar chain found on bromelain turned up in 23 percent of 1,831 people tested for respiratory allergies in one survey, and in 31 percent of those allergic to pollen, yet those antibodies rarely cause symptoms.
Bleeding. This is the caution you will see everywhere, and the evidence behind it is mostly indirect. Bromelain reduces platelet clumping in test tubes, at concentrations far above those measured in human blood, and it reduced clot formation in rats at an oral dose that, scaled by body surface area, equals roughly 600 to 700 milligrams for an adult. In a small 1999 German study of oral bromelain at 3,000 FIP units a day for 10 days, the abstract reports that one standard clotting test, the aPTT, rose from 38 to 46 seconds in plasma from healthy donors; it does not say how many donors took part. In lab tests with human liver enzymes, bromelain strongly inhibited CYP2C9, the enzyme that clears warfarin and several anti-inflammatory painkillers, an effect that has not been tested in people. On the other side, we found no published case reports in PubMed of bleeding linked to oral bromelain (the bleeding and clotting reports we found involve the NexoBrid burn gel), the surgical trials we reviewed did not report bleeding problems, and two found less bruising. Two observational studies of 260 surgical patients given low-molecular-weight heparin to prevent blood clots, 129 of them also given bromelain, found only marginal changes in clotting tests, but they say nothing directly about warfarin, newer anticoagulants, or antiplatelet drugs. The German label still says not to combine bromelain with anticoagulants or antiplatelet drugs and to stop it before surgery, and that is the sensible default.
Antibiotics. The German label states that bromelain raises blood and urine levels of antibiotics, while also noting that no systematic interaction studies exist. The idea grew out of 1960s studies of other enzymes and a 1972 German study of bromelain with tetracycline. The one study we could read in full, a 1978 crossover study in 10 healthy volunteers, found that a single 80 milligram dose of enteric-coated bromelain, about one German tablet but well below most US supplement doses, made no significant difference to how much tetracycline was absorbed, and its authors pointed out that the earlier positive study had run no formal statistical tests. If you are prescribed an antibiotic, tell your pharmacist that you take bromelain.
Blood pressure medicines. Some websites warn that bromelain raises levels of the blood pressure drugs called ACE inhibitors. We found no human study showing that, and the German label does not name them. The label does say, more generally, that bromelain may increase the absorption of other medicines taken at the same time, that it should be combined with other drugs only after weighing benefits and risks, and that any drug with a narrow margin between an effective and a harmful dose should be monitored and its dose adjusted if needed.
Pregnancy and children. There is no safety data in pregnancy or breastfeeding, and the German label advises against use in both. It also says not to use bromelain in children under 12, and a 2024 review found no conclusive evidence for its use in children.
You take a blood thinner such as warfarin or a newer anticoagulant, or an antiplatelet medicine such as aspirin or clopidogrel, or you have a bleeding disorder: the German drug label says not to use bromelain in any of these cases. You have surgery or dental work scheduled: the German drug label advises stopping bromelain beforehand, so use it around a procedure only if your surgeon agrees. You take an antibiotic or a drug with a narrow safety margin. You are pregnant or breastfeeding, or the product is for a child. You are allergic to latex or papain. If you are allergic to pineapple, do not take bromelain at all. You have severe liver or kidney disease. Stop taking it and seek care if you develop a rash, wheezing, or unusual bruising or bleeding. Do not use bromelain in place of treatment for an infection, arthritis, or recovery from surgery.
Frequently asked questions
What is bromelain good for?
Its most consistent result is a small reduction in pain after wisdom tooth surgery, found in several small trials and in four meta-analyses that disagree about when the benefit appears and whether swelling improves. In older trials of acute sinusitis, adding it to standard treatment improved some symptoms, and Germany licenses a low-dose bromelain tablet as an add-on for swelling after operations and injuries, especially of the nose and sinuses. The one placebo-controlled trial of bromelain alone in knee arthritis found no benefit, and trials in muscle soreness, along with a large ankle sprain trial of a bromelain blend, were null. Apart from the muscle soreness trials, which were in healthy volunteers and found no benefit, these studies were in people with a medical condition or recovering from surgery, so none of this shows a benefit for a healthy person.
How much bromelain do studies use?
Trials of bromelain on its own used roughly 100 to 1,000 milligrams a day, usually split into two to four doses, for a few days to two weeks around surgery or up to 16 weeks for knee pain. In the one placebo-controlled dose-finding trial, after wisdom tooth surgery, higher doses did no better than the lowest, although an open study of mild knee pain without a placebo group found 400 milligrams a day did better than 200. The licensed German medicine uses a lower dose by weight than most of those trials: one tablet of 56 to 95 milligrams, labeled as 500 FIP units, once or twice a day for no more than four to five days without medical advice. Because potency varies, compare products by activity per serving rather than milligrams. This is a description of the research, not a dosing recommendation.
What does GDU mean on a bromelain label?
GDU stands for gelatin digesting units, a measure of how fast the enzyme breaks down gelatin. It tells you the activity, which matters more than the weight. A common grade is 2,400 GDU per gram, so a 500 milligram capsule of that grade supplies about 1,200 GDU. European products often use FIP units, which come from a different test, and there is no exact conversion between the two.
Should bromelain be taken with food or on an empty stomach?
No human study has compared the two. Some trials of bromelain for swelling, and the German drug label, give it apart from food, with the label specifying about half an hour before a meal. Digestive enzyme products that contain bromelain are meant to be taken with meals. The advice you see either way is convention rather than tested practice.
Does bromelain help the body absorb quercetin?
We found no human study that measured it. The most-cited source we could find is a 1999 prostatitis trial whose abstract asserts, without data, that bromelain and papain enhance bioflavonoid absorption. Its placebo-controlled comparison tested quercetin on its own, and the bromelain-containing product was given only in an unblinded follow-up group with no absorption measurements. Quercetin forms with actual absorption data, such as phytosome or enzymatically modified isoquercitrin, are a better bet.
What are the side effects of bromelain?
In short trials it is generally well tolerated. The most common complaints are digestive, such as gas, nausea, stomach upset, and diarrhea, along with headache. Allergic reactions, including rash and asthma-like symptoms, are the main concern, and the German drug label lists them as common, affecting between 1 in 100 and 1 in 10 users. People allergic to pineapple should not take it, and people with latex allergy or an allergy to papain may react too. Long-term safety has not been studied.
Is bromelain safe with blood thinners?
Not without your clinician's approval. The German drug label says not to combine it with anticoagulants or antiplatelet drugs and to stop it before surgery. The evidence behind that caution is mostly laboratory and animal work, plus one small study reporting a longer result on a standard clotting test, and a lab study showing bromelain blocks a liver enzyme that clears warfarin. We found no published case reports of bleeding linked to oral bromelain, but no one has shown that combining it with warfarin, a newer anticoagulant, or an antiplatelet drug is safe, so do not add it to a blood thinner on your own.
Can you get bromelain by eating pineapple?
Not in any reliable dose. Most supplements are made from pineapple stem, whose main enzyme differs from the one in the fruit, and the amount in fruit is not standardized. Heat inactivates the enzyme, which is why canned pineapple can set in gelatin while fresh pineapple cannot. No trial has tested eating pineapple for the uses discussed here, although pineapple is a perfectly good food.
Is bromelain better than serrapeptase or nattokinase?
Bromelain has the stronger evidence base of the three for swelling and pain, including a human study showing that some of it reaches the blood, although only in trace amounts. Serrapeptase has fewer published trials, and the larger trials run by its original maker, which as far as we can find were never published in a journal, missed their main goals. Nattokinase is studied for a different purpose, with a modest blood pressure signal in small trials. None of the three has a trial showing a meaningful benefit in healthy people.
The bottom line
Bromelain earns its reputation as the best-studied systemic enzyme, but that is a low bar. Its most consistent result is a small reduction in pain after wisdom tooth surgery, and even there the pooled reviews disagree about timing and about swelling. The one placebo-controlled trial of bromelain alone in knee arthritis was null, the muscle soreness trials and a large sprain trial of a bromelain blend were null, the sinus data are old or non-randomized, and the digestion evidence comes from a single 1970 trial in a medical condition. Some bromelain does reach the blood, in trace amounts, and there is no human evidence that it improves quercetin absorption. If you choose to try it, buy by GDU from a brand that shows third-party testing, and skip it or clear it with a clinician if you take a blood thinner, have surgery coming up, or are pregnant, and do not take it at all if you are allergic to pineapple.